MKMadeleine C. Kline

Madeleine C. Kline

*This is an algorithmically generated author record based on publicly available information.

Madeleine C. Kline has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Impact of Doxycycline Post-Exposure Prophylaxis on Antibiotic Use at a Boston Sexual Health Clinic

    by Rachel Mittelstaedt, David Helekal, Madeleine C. Kline, Kirstin I. Oliveira Roster, Gregory K. Robbins, Kevin L. Ard, Yonatan H. Grad

    Background: Doxycycline post-exposure prophylaxis (doxy-PEP) reduces the incidence of bacterial sexually transmitted infections (STIs) among men who have sex with men and transgender women (MSMTW), but it may select for antimicrobial resistance (AMR). AMR development will depend in part how doxy-PEP changes rates of antibiotic use. Methods: We conducted a retrospective electronic medical record review of antibiotic prescriptions received by patients at the Massachusetts General Hospital Sexual Health Clinic from January 1, 2023, to December 27, 2025. Using a Bayesian negative binomial regression, we assessed the direct, indirect, and combined effects of doxy-PEP implementation on antibiotic prescription rates among doxy-PEP-eligible MSMTW who were receiving HIV pre-exposure prophylaxis. Results: Controlling for direct effects, the cohort’s total antibiotic prescription rate decreased by 10% (0.90, 95% CI 0.87 – 0.94) for every 100 doxy-PEP starts. Doxy-PEP users were prescribed antibiotics at double the rate predicted in the absence of doxy-PEP implementation, and, controlling for indirect effects, received 3.40 (95% CI 2.95 – 3.91) times the antibiotic prescriptions of patients not using doxy-PEP. Doxy-PEP non-users were prescribed antibiotics at less than half the rate predicted in the absence of doxy-PEP. The full cohort’s overall antibiotic prescription rate increased by 1.4 times after doxy-PEP implementation. Conclusions: Individuals who are taking doxy-PEP have higher antibiotic prescription rates, increasing selection for antibiotic-resistant bacteria in these individuals. However, doxy-PEP-driven decreases in the overall incidence of bacterial STIs have the potential to decrease selective pressure for resistant organisms in those not using doxy-PEP.


  • Open Access

    Inferring Sexual Network Bridging Using Genomics: A Simulation Study

    by Madeleine C. Kline, David Helekal, Kirstin I Oliveira Roster, Yonatan Grad

    The dynamics of sexually transmitted infections involve interconnected transmission networks, including men who have sex with men and heterosexual populations. Understanding the extent of bridging between these networks can inform surveillance, guide interventions, and aid in the interpretation of their impact, but methods for quantifying bridging have been lacking. Here, we addressed whether pathogen genomics tools, successfully used to reconstruct transmission in other contexts, could accurately infer sexual network bridging. Based on simulations of gonorrhea spread, we evaluated phylodynamic bridging metrics inferred by ancestral state reconstruction under a range of sampling schemes, from comprehensive to sparse. These metrics differentiated sexual network structures even with biased sampling schemes, but accuracy depended on the sampling scheme and density: phylodynamic bridging estimates using sequences from all detected infections for one network configuration were on average 6.9% above the true value, whereas estimates from 5% of infections in symptomatic men with many partners were on average >1000% above the true value. These results suggest routine overestimation of bridging from unadjusted inferences from genomics data and provide context for interpreting existing genomic surveillance data and targeted studies.

  • Open Access

    Comparing Strategies to Introduce Two New Antibiotics for Gonorrhea: A Modeling Study

    by Madeleine C. Kline, Kirstin Oliveira Roster, David Helekal, Eva Rumpler, Yonatan H. Grad

    Introduction: Drug resistance in Neisseria gonorrhoeae is an urgent public health threat. The anticipated approval of two new antimicrobials for gonorrhea prompts the need for evidence-based rollout strategies that minimize drug resistance. Methods: We used a stochastic compartmental model of men who have sex with men (MSM) in the United States (U.S.) to compare two main strategies—equal allocation and sequential drug deployment—for two new and one existing drug and measured the time for each drug to reach a resistance prevalence threshold of 5%. We conducted broad analyses assessing the sensitivity of our results to wide variation in parameters governing the baseline behavior of the model and drug resistance evolution and fitness. Results: Compared to the equal allocation strategy, the sequential strategy had reached the resistance prevalence threshold i) for each drug individually in at least as many simulations; ii) for all three drugs in at least as many simulations; and iii) for at least as many drugs on average. Aber 10 years, no equal allocation strategy simulations had met the 5% resistance prevalence threshold for any of the drugs, whereas 99.6% of sequential simulations had for the first drug, of which 3.5% had also met the threshold for the second drug. The sequential strategy was worse for nearly every reasonable combination of model parameters. Conclusion: In a model of U.S. MSM, the equal allocation strategy for introducing new drugs for gonorrhea matched or outperformed the strategy of sequential introduction in terms of resistance prevalence. Summary: Immediately introducing two new antibiotics to treat gonorrhea alongside one currently used therapy is more effective at minimizing drug resistance than holding the new drugs in reserve.


  • Open Access

    Climate Change, Environment, and Health: The implementation and initial evaluation of a longitudinal, integrated curricular theme and novel competency framework at Harvard Medical School

    by Madeleine C. Kline, Julia R. Malits, Natalie Baker, Hugh Shirley, Ben Grobman, William Éamon Callison, Stephen Pelletier, Kari Nadeau, David S. Jones, Gaurab Basu

    Climate change, air pollution, and ecological degradation impact health through numerous, complex mechanisms. To train future physicians to understand these impacts, medical schools can deliver longitudinal climate curricula in undergraduate medical education, but the field remains nascent. This report describes the development, implementation, and evaluation of the longitudinal, integrated Climate Change, Environment, and Health curricular theme and novel competency framework at Harvard Medical School (HMS). A group of HMS students collaborated with faculty to integrate climate content into the pre-clerkship curriculum. The team subsequently pursued institutional recognition as a formal HMS curricular theme and created a new competency framework that guided curriculum integration mapping and evaluation tool development. The competencies cover the impact of climate change, air pollution, and ecological degradation on health in the context of historical and structural inequities and explore the role of healthcare in contributing to both climate change and solutions. A retrospective, eight-item survey using a seven-point Likert scale and two open-ended questions was administered at the end of the pre-clerkship curriculum. HMS approved a required, four-year Climate Change, Environment, and Health curricular theme in January 2023. Survey data from 100/134 (74.6%) study participants showed that most students agreed (somewhat agree/agree/strongly agree) the curricular theme was valuable (76.0%) and improved their understanding of the health impacts of climate change (80.0%). Most students agreed that their abilities in the five competencies improved because of exposure to the curricular theme. Qualitative comments indicated that students found the curriculum valuable, and also provided constructive feedback. Efforts to expand the curriculum to all four years of medical school and conduct further evaluation continue. Further scholarship is needed to present different curricular approaches and competency frameworks, which can ultimately support effective training of future physicians to understand and respond to the impacts of climate change on health and health equity.


  • Spatiotemporal Trends in Group A Streptococcal Pharyngitis in the United States

    by Madeleine C Kline, Stephen M Kissler, Lilith K Whittles, Michael L Barnett, Yonatan H Grad

    Group A Streptococcus (GAS) causes an estimated 5.2 million outpatient visits for pharyngitis annually in the United States (U.S.) with incidence peaking in winter, but the annual spatiotemporal pattern of GAS pharyngitis across the U.S. is poorly characterized. We used outpatient claims data from individuals with private medical insurance between 2010-2018 to quantify GAS pharyngitis visit rates across U.S. census regions, subregions, and states. We evaluated seasonal and age-based patterns of geographic spread and the association between school start dates and the summertime upward inflection in GAS visits. The South had the most visits per person (yearly average 39.11 visits per 1000 people, 95% CI: 36.21-42.01), and the West had the fewest (yearly average 17.63 visits per 1000 people, 95% CI: 16.76-18.49). Visits increased earliest in the South and in school-age children. Differences in visits between the South and other regions were most pronounced in the late summer through early winter. Visits peaked earliest in central southern states, in December to January, and latest on the coasts, in March. The onset of the rise in GAS pharyngitis visits correlated with, but preceded, average school start times. The burden and timing of GAS pharyngitis varied across the continental U.S., with the South experiencing the highest overall rates and earliest onset and peak in outpatient visits. Understanding the drivers of these regional differences in GAS pharyngitis will help in identifying and targeting prevention measures. This graphical abstract is also available at Tidbit: https://tidbitapp.io/tidbits/spatiotemporal-trends-in-group-a-streptococcal-pharyngitis-in-the-united-states


  • Open Access

    1782. Spatiotemporal Trends in Group A Streptococcal Pharyngitis in the United States

    by Madeleine Kline, Stephen M Kissler, Yonatan H Grad

    Pharyngitis caused by group A Streptococcus (GAS) drives many outpatient pharyngitis visits and antibiotic prescriptions in the US and can have serious post-infection immunological sequelae. Like many other upper respiratory infections, GAS pharyngitis burden is usually highest in the winter. However, compared to other common illnesses such as RSV or influenza, relatively little is known about the spatiotemporal distribution of GAS pharyngitis in the US. We analyzed outpatient claims data to better characterize regional differences in the burden and seasonal timing of GAS pharyngitis across US census regions. US outpatient insurance claims from private insurers for GAS pharyngitis were extracted from the IBM MarketScan database from 2010-2018. Data were weighted to be representative of the overall population, and visits per month were averaged across the US census regions. Seasonal trends were assessed by fitting sinusoids to monthly state-, and region- level data using nonlinear-least squares regression. The South had consistently more GAS pharyngitis visits per 1000 people compared to the other regions, and the West had fewer visits per 1000 people (South January Average: 3.78, 95% CI 3.36-4.21, West January Average: 1.76, 95% CI 1.62-1.90) (Fig. 1). The wintertime peak in visits began its rise earlier in the South than other regions, and the regional differences in visits were most pronounced from July through December. Annual GAS pharyngitis visits peaked earliest in the South, particularly the West and East South Central subregions, in February (West South Central peak month: 1.49, 95% CI 1.20-1.77; East South Central peak month: 1.50, 95% CI 1.22-1.79), then radiated outwards peaking last in March on the coasts (Pacific West peak month: 2.35, 95% CI 2.10-2.61; New England peak month 2.62, 95% CI 2.44-2.81) (Fig. 2). GAS pharyngitis visits showed distinct regional trends in burden and seasonality. These regional differences could indicate where and when to expect the most severe disease, complications, and sequelae. Further investigation is needed to uncover the mechanism of these differences –including socio-behavioral, environmental, or circulating strain– and to target interventions to reduce burden of disease. Stephen M. Kissler, PhD, ModernaTx: Advisor/Consultant Yonatan H. Grad, MD, PhD, Day Zero Diagnostics: Board Member|GSK: Advisor/Consultant

  • Open Access

    Spatiotemporal Trends in Group A Streptococcal Pharyngitis in the United States

    by Madeleine C. Kline, Stephen M. Kissler, Lilith K. Whittles, Michael L. Barnett, Yonatan H. Grad

    Background: Group A Streptococcus (GAS) causes an estimated 5.2 million outpatient visits for pharyngitis annually in the United States (U.S.) with incidence peaking in winter, but the annual spatiotemporal pattern of GAS pharyngitis across the U.S. is poorly characterized. Methods: We used outpatient claims data from individuals with private medical insurance between 2010-2018 to quantify GAS pharyngitis visit rates across U.S. census regions, subregions, and states. We evaluated seasonal and age-based patterns of geographic spread and the association between school start dates and the summertime upward inflection in GAS visits. Results: The South had the most visits per person (yearly average 39.11 visits per 1000 people, 95% CI: 36.21-42.01), and the West had the fewest (yearly average 17.63 visits per 1000 people, 95% CI: 16.76-18.49). Visits increased earliest in the South and in school-age children. Differences in visits between the South and other regions were most pronounced in the late summer through early winter. Visits peaked earliest in central southern states, in December to January, and latest on the coasts, in March. The onset of the rise in GAS pharyngitis visits correlated with, but preceded, average school start times. Conclusions: The burden and timing of GAS pharyngitis varied across the continental U.S., with the South experiencing the highest overall rates and earliest onset and peak in outpatient visits. Understanding the drivers of these regional differences in GAS pharyngitis will help in identifying and targeting prevention measures. Summary: The incidence of streptococcal pharyngitis varies across the U.S., with highest rates in the South and lowest in the West. On average, the yearly summer increase in cases begins in the South and progresses outwards to adjacent states.